Just the EU partnership, FDA application for expanded use, possible extended patent protection as a novel molecular therapy, and the weekly scrips numbers.
as this company grows, it will be in more and more biotech and broader indexes and mutual funds, many of which were forced to sell the company when it was below $5. They are now back, and will be increasing their size.
I think It will go from 7 to 8 next week or possibly the following, but fairly soon and it will probably remain rangebound around 8 until the next catalyst. The resistance points are fairly well defined from the trip downward. I state this as a person who invests based upon value, not resistance and trend, but I do know how to read a chart and understand that technicals are controlling the movements lately. I certainly hated that last year, but I do not mind at the moment.
this is a good buy down here. A real business that makes income and distributes to the shareholders. They also have a history of buying back shares in the low 20s when the market gives them the chance. I wonder now.
They are selling lots of pills.
And your poor use of exclamation points does not add credence to your words. Rather, their effect is to make you appear childish, in addition to the obvious duplicitous nature of your research.
I have no respect for you!!!!
Huh? Maybe you meant to reply to the message above mine, or maybe your reading comprehension is not strong enough to understand my point. Perhaps it was a bit of both. In any event, the report is out.
No company that goeth down for a few consecutive days mayeth ever be subsequently acquired, no matter what. -Leviticus.
It is at least partially the existence of a large holder that allows for shorts to manipulate the stock. Consider that because Baupost is not trading 40% of the company, and another 40% is held by people that are not selling in the single digits no matter what, you are left with a small part of the company that actually does trade, and this creates illiquidity that manifests in violent moves up and down when the tides turn. And the tides are turning.
The tax treatment would depend upon the nature of the acquisition and how they account for it. Whether it is a cash acquisition or bought with shares could affect whether a true "sale" occurs that would trigger a gain/loss.